A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill. For years, effective antiretroviral treatment has required HIV-positive patients to take a large handful ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

A digital pill that records when it is taken has been ... treatment used to protect them from contracting HIV. A pilot study, which involved 16 men who have sex with men (MSM) and a history ...

with a trial demonstrating that people receiving this drug had 90 percent less risk of contracting HIV compared with oral pills. Yet access has been the major hurdle. Last month a new study ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...